Utilization of HER2 Genetic Testing in a Multi-Institutional Observational Study

Human epidermal growth factor receptor 2 (HER2) expression is amplified in about 20% of breast cancer tumors, and evaluation of HER2 status should influence therapy selection. A critical gap in our knowledge is the real-world implementation of HER2 testing and its impact on treatment decisions for w...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Goddard, Katrina A.B., Aiello Bowles, Erin J., Feigelson, Heather Spencer, Habel, Laurel A., Alford, Sharon Hensley, McCarty, Catherine M., Nekhlyudov, Larissa, Onitilo, Adedayo A., Rahm, Alanna, Webster, Jennifer A.
Format: Artigo
Idioma:Inglês
Publicat: 2012
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4061608/
https://ncbi.nlm.nih.gov/pubmed/23198713
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars